Effect of ganaxolone and THIP on operant and limited-access ethanol self-administration
Marcia J. Ramaker, Moriah N. Strong, Matthew M. Ford, Deborah A. Finn
Index: Neuropharmacology 63(4) , 555-64, (2012)
Full Text: HTML
Abstract
Recent evidence suggests that GABAA receptor ligands may regulate ethanol intake via effects at both synaptic and extrasynaptic receptors. For example, the endogenous neurosteroid, allopregnanolone (ALLO) has a similar pharmacological profile as ethanol, and it alters ethanol intake in rodent models. Additionally, recent evidence suggests that δ-subunit-containing extrasynaptic GABAA receptors may confer high sensitivity to both ethanol and neurosteroids. The purpose of the present study was to determine the effects of ganaxolone (GAN; an ALLO analog) and gaboxadol (THIP; a GABAA receptor agonist with selectivity for the extrasynaptic δ-subunit) on ethanol intake, drinking patterns, and bout characteristics in operant and limited-access self-administration procedures. In separate studies, the effects of GAN (0–10 mg/kg) and THIP (2–16 mg/kg) were tested in C57BL/6J male mice provided with 2-h access to a two-bottle choice of water or 10% ethanol or trained to respond for 30 min of access to 10% ethanol. GAN had no overall significant effect on operant ethanol self-administration, but tended to decrease the latency to consume the first bout. In the limited-access procedure, GAN dose-dependently decreased ethanol intake. THIP dose-dependently decreased ethanol intake in both paradigms, altering both the consummatory and appetitive processes of operant self-administration as well as shifting the drinking patterns in both procedures. These results add to literature suggesting time-dependent effects of neurosteroids to promote the onset, and to subsequently decrease, ethanol drinking behavior, and they support a role for extrasynaptic GABAA receptor activation in ethanol reinforcement.
Related Compounds
Related Articles:
2015-01-22
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 976-977 , 6-18, (2015)]
2005-02-01
[Xenobiotica 35 , 191-210, (2005)]
2015-09-15
[Behav. Brain Res. 291 , 164-71, (2015)]
2014-11-01
[Epilepsy Res. 108(9) , 1492-500, (2014)]
2010-01-29
[Neurosci. Lett. 469(3) , 396-9, (2010)]